A case of actinic cheilitis treated by topical photodynamic therapy with methyl aminolevulinate

Korean Journal of Dermatology

Volumn 46, Issue 6, 2008, Pages 835-838

  Huh, Chang Hun ^a   Lee, Hye In ^b   Rho, Yong Kwan ^b   Kim, Beom Joon ^b   Kim, Myeung Nam ^b   Song, Kye Yong ^b   Lee, Ju Hee ^c  

^a Seoul National University Bundang Hospital   (South Korea)

^b Chung Ang University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Actinic cheilitis; Methyl aminolevulinate; Photodynamic therapy

Indexed keywords

EID: 51349104307     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Picascia DD, Robinson JK. Actinic cheilitis: a review of the etiology, differential diagnosis, and treatment. J Am Acad Dermatol 1987:17:255-264
2. Kodama M, Watanabe D, Akita Y, Tamada Y, Matsumoto Y. Photodynamic therapy for the treatment of actinic cheilitis. Photodermatol Photoimmunol Photomed 2007:23: 209-210
3. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976:36:2326-2329
4. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997:79:2282-2308
5. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002:146:552-567
6. Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003:48:227-232
7. Kloek J, Beijersbergen van Henegouwen GMJ. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 1996:64:994-1000
8. Fritsch C. Homey B, Stahl W, Lehmann P, Ruzicka T. Sies H. Preferential relative porphyrin enrichment in solar keratoses upon topical application of 5-aminolevulinic acid methylester. Photochem Photobiol 1998:68:218-221
9. Rud E, Gederaas O, Hogset A, Berg K. 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 2000:71:640-647
10. Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Dis 2004:10:212-216
11. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993:85:443-456
12. Moan J. Properties for optimal PDT sensitizers. J Photochem Photobiol B 1990;5:521-524
13. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 2004:30:264-271
14. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000:42:389-413
15. Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2002:143: 699-700
16. Brown SB. The role of light in the treatment of nonmelanoma skin cancer using methyl aminolevulinate. J Dermatolog Treat 2003;14(Suppl. 3):11-14